In last trading session, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) saw 4.58 million shares changing hands with its beta currently measuring 1.37. Company’s recent per share price level of $2.17 trading at -$0.05 or -2.25% at ring of the bell on the day assigns it a market valuation of $784.43M. That closing price of LXRX’s stock is at a discount of -71.89% from its 52-week high price of $3.73 and is indicating a premium of 57.6% from its 52-week low price of $0.92. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.86 million shares which gives us an average trading volume of 2.67 million if we extend that period to 3-months.
For Lexicon Pharmaceuticals Inc (LXRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) trade information
Upright in the red during last session for losing -2.25%, in the last five days LXRX remained trading in the green while hitting it’s week-highest on Wednesday, 07/24/24 when the stock touched $2.17 price level, adding 6.87% to its value on the day. Lexicon Pharmaceuticals Inc’s shares saw a change of 41.83% in year-to-date performance and have moved 1.88% in past 5-day. Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) showed a performance of 19.89% in past 30-days. Number of shares sold short was 20.2 million shares which calculate 7.86 days to cover the short interests.
Lexicon Pharmaceuticals Inc (LXRX) estimates and forecasts
Statistics highlight that Lexicon Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 35.63% of value to its shares in past 6 months, showing an annual growth rate of 11.39% while that of industry is 15.30. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 6.80% during past 5 years.
LXRX Dividends
Lexicon Pharmaceuticals Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s Major holders
Insiders are in possession of 1.15% of company’s total shares while institution are holding 72.83 percent of that, with stock having share float percentage of 73.68%. Investors also watch the number of corporate investors in a company very closely, which is 72.83% institutions for Lexicon Pharmaceuticals Inc that are currently holding shares of the company. ARTAL GROUP S.A. is the top institutional holder at LXRX for having 117.55 million shares of worth $282.13 million. And as of 2024-03-31, it was holding 53.1603 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 13.89 million shares on 2024-03-31. The number of shares represents firm’s hold over 6.2832 of outstanding shares, having a total worth of $33.35 million.
